Evaluate the Efficacy and Safety of Different Doses of Edaravone Dexborneol Concentrated Solution for Injection Combined With Conventional Medical Therapy in the Treatment of Patients With Cerebral Hemorrhage
Clinical trial NCT05953103 · TERMINATED
Trial details
- NCT number
- NCT05953103
- Sponsor
- Simcere Pharmaceutical Co., Ltd
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-03
- Primary completion
- 2025-04-02
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.